Mutual of America Capital Management LLC Cuts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Mutual of America Capital Management LLC trimmed its holdings in shares of IQVIA Holdings Inc. (NYSE:IQVFree Report) by 4.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 25,690 shares of the medical research company’s stock after selling 1,059 shares during the period. Mutual of America Capital Management LLC’s holdings in IQVIA were worth $5,055,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. ST Germain D J Co. Inc. acquired a new stake in IQVIA during the 2nd quarter valued at approximately $33,000. Live Oak Investment Partners acquired a new stake in IQVIA during the 4th quarter valued at approximately $41,000. MBM Wealth Consultants LLC acquired a new stake in IQVIA during the 4th quarter valued at approximately $51,000. KB Financial Partners LLC acquired a new stake in IQVIA during the 1st quarter valued at approximately $53,000. Finally, Parkside Financial Bank & Trust lifted its stake in IQVIA by 19.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 293 shares of the medical research company’s stock valued at $66,000 after acquiring an additional 48 shares during the period. 86.82% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at IQVIA

In other news, insider Kevin C. Knightly sold 13,117 shares of the company’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $214.03, for a total transaction of $2,807,431.51. Following the completion of the sale, the insider now owns 7,347 shares of the company’s stock, valued at $1,572,478.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on IQV. Truist Financial lifted their price objective on shares of IQVIA from $240.00 to $286.00 and gave the company a “buy” rating in a research note on Thursday, January 4th. Morgan Stanley decreased their target price on shares of IQVIA from $240.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, November 3rd. JPMorgan Chase & Co. decreased their target price on shares of IQVIA from $262.00 to $239.00 and set an “overweight” rating for the company in a research note on Monday, November 13th. StockNews.com cut shares of IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday, February 8th. Finally, Barclays boosted their target price on shares of IQVIA from $215.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.31.

View Our Latest Report on IQVIA

IQVIA Price Performance

Shares of NYSE IQV opened at $217.88 on Tuesday. The firm has a market cap of $39.76 billion, a PE ratio of 36.62, a PEG ratio of 2.49 and a beta of 1.48. The firm has a fifty day moving average of $219.72 and a 200 day moving average of $211.12. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.79 and a current ratio of 0.79. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $234.92.

IQVIA Company Profile

(Free Report)

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

See Also

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQVFree Report).

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.